Technical Analysis for BCAB - BioAtla, Inc.

Grade Last Price % Change Price Change
D 40.24 -0.30% -0.12
BCAB closed up 3.12 percent on Wednesday, July 28, 2021, on 42 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Flat
Historical BCAB trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction -0.30%
Multiple of Ten Bullish Other -0.30%
Inside Day Range Contraction -0.30%
50 DMA Resistance Bearish 2.81%
Fell Below 20 DMA Bearish 2.81%
Bollinger Band Squeeze Range Contraction 2.81%
Multiple of Ten Bearish Other 2.81%
50 DMA Resistance Bearish -2.97%
Crossed Above 20 DMA Bullish -2.97%
Bollinger Band Squeeze Range Contraction -2.97%
Older End-of-Day Signals for BCAB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below 10 DMA about 1 hour ago
Possible Pocket Pivot about 2 hours ago
60 Minute Opening Range Breakdown about 4 hours ago
10 DMA Support about 5 hours ago
20 DMA Resistance about 6 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. It also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. The company was founded in 2007 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Clinical Medicine Drugs Cancers Health Care Cancer Immunotherapy Monoclonal Antibodies Non Small Cell Lung Cancer Small Cell Lung Cancer Tumor Melanoma Targeted Therapy Bladder Cancer Renal Cell Carcinoma Hepatocellular Carcinoma Nsclc Cervical Cancer Non Small Cell Lung Carcinoma Gastric Cancer

Is BCAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 76.63
52 Week Low 27.15
Average Volume 207,393
200-Day Moving Average 0.00
50-Day Moving Average 41.57
20-Day Moving Average 40.90
10-Day Moving Average 40.08
Average True Range 2.37
ADX 10.81
+DI 17.02
-DI 22.20
Chandelier Exit (Long, 3 ATRs) 40.48
Chandelier Exit (Short, 3 ATRs) 44.48
Upper Bollinger Bands 44.08
Lower Bollinger Band 37.71
Percent B (%b) 0.42
BandWidth 15.58
MACD Line -0.55
MACD Signal Line -0.64
MACD Histogram 0.0816
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.57
Resistance 3 (R3) 42.43 41.54 42.20
Resistance 2 (R2) 41.54 40.98 41.61 42.08
Resistance 1 (R1) 40.95 40.63 41.25 41.10 41.96
Pivot Point 40.07 40.07 40.21 40.14 40.07
Support 1 (S1) 39.48 39.50 39.77 39.62 38.76
Support 2 (S2) 38.59 39.15 38.66 38.64
Support 3 (S3) 38.00 38.59 38.52
Support 4 (S4) 38.15